SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

UBS Maintains Buy on Globus Medical, Lowers Price Target to $61

UBS maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $67 to $61.

Benzinga · 05/08/2020 18:06

UBS maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $67 to $61.